https://lucius-pharmaceuticals.com/disease/chronic-fibrosing-interstitial-lung-diseases-ilds/
chronic fibrosing interstitial lung diseases (ILDs) - Lucius Pharmaceuticals
interstitial lung diseaseschronicfibrosingildslucius
https://www.europeanhhm.com/researchinsights/supporting-self-management-for-patients-with-interstitial-lung-diseases-utility-and-acceptability-of-digital-devices
Supporting self-management for patients with Interstitial Lung Diseases: Utility and acceptability...
Patients diagnosed with Interstitial Lung Diseases (ILD) use devices to self-monitor their health and well-being. Little is known about the range of devices,...
interstitial lung diseasesself managementfor patientssupportingutility
https://www.cmeaims.org/virtuemart-product-details/therapeutic-area/pediatrics/childhood-interstitial-lung-diseases-increasing-awareness,-diagnosis,-and-multidisciplinary-patient-management-detail
Childhood Interstitial Lung Diseases: Increasing Awareness, Diagnosis, and Multidisciplinary...
Hear expert faculty discuss chILD to address ongoing professional practice gaps and educational needs related to early patient identification, appropriate...
interstitial lung diseaseschildhoodincreasingawarenessdiagnosis
https://encyclopedia.pub/entry/46956
Artificial Intelligence Applications in Interstitial Lung Diseases | Encyclopedia MDPI
Encyclopedia is a user-generated content hub aiming to provide a comprehensive record for scientific developments. All content free to post, read, share and...
interstitial lung diseasesartificial intelligenceapplicationsencyclopediamdpi
https://www.francefoundation.com/education/therapeutic-areas/oncology/disease-area/interstitial-lung-disease/nintedanib-in-progressive-fibrosing-interstitial-lung-diseases-the-inbuild-trial-detail
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
Continue your education on Nintedanib in Progressive Fibrosing Interstitial Lung Disease with this video. Here our experts discuss their opinions. Watch here!
interstitial lung diseasesnintedanibprogressivefibrosinginbuild